199936 (OTHER) by hospital — Price Transparency

OTHER · across hospitals

199936 — Brexucabtagene Autoleucel, Up To 200 Million Autologous Anti-cd19 Car Positive Viable T Cells, Including Leukapheresis And Dose Preparation Procedures, Per Therapeutic Dose

Hospital-by-hospital median negotiated rates. Hospitals are ranked by their typical (median) negotiated rate (highest first by default; click a column to re-sort). Outliers are flagged where a hospital's median is more than 2× or less than 0.5× the cohort median (red = high, green = low).

$1,031,736 National median

$1,031,736 Cohort median

1 hospitals

1 states (national)

View state-by-state → Raw rate rows →

Estimate your cost

What would you pay?

Plug in your deductible, what you've already spent against it, your OOP-max, and your coinsurance %. We'll math the rest. Math reference: methodology.

This estimate runs on the hospital’s facility charge only. The surgeon’s and anesthesiologist’s fees are billed separately and aren’t in this number — your EOB shows your complete total.

I am… Annual deductible (assumed — typical plan) Already spent this year

Checked your insurer’s portal? Enter your remaining deductible and out-of-pocket max above/below and leave “already spent” at 0.

Out-of-pocket max (assumed — typical plan) Coinsurance % (after deductible)

Loading estimate…

Outliers ↑ 0 high ↓ 0 low out of 1 hospital

Median negotiated rate, by hospital

Ranked by typical (median) negotiated price. Red = high outlier, green = low outlier, slate = in-range. Hover for IQR.

Median negotiated rate by hospital for 199936 (OTHER)
Hospital	State	Median	p25	p75	Outlier flag
FRANCISCAN HEALTH INDIANAPOLIS	IN	$1,031,736	$445,200	$1,619,680	in range

Sortable, filterable data table. Use the column headers to sort, the filter row to narrow results.
Hospital	State	City	Median	p25	p75	Min	Max	Cash $	Payers	Rates	Outlier

FRANCISCAN HEALTH INDIANAPOLIS	IN	Indianapolis	$1,031,736	$445,200	$1,619,680	<$1	$1,619,680	$443,792	31	62	in range